A trial is under way to examine the effectiveness of a number of novel treatments for multiple myeloma.
The 'ProMMise' trial is run by a team of researchers led by Dr Rakesh Popat of University College London Hospitals. The trial was developed und...
2 years ago
New European guidance has recommended that a second COVID-19 vaccine booster shot is given to 'moderately and severely immunocompromised' people from five years of age.
This includes people who are receiving active treatment for blood cancer or ha...
2 years ago
